Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-065220

SVP, COO & CFO acquired 40,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2021-11-15 Grant or award +40,150 280,831 D: show line 1 in the form
Loading xslF345X03/doc4.xml…